Loading clinical trials...
Loading clinical trials...
The SCOPE study is an observational, multicenter, prospective cohort study aimed at evaluating a 2-year screening programme for CKD in a population of older patients, aged 75 years or more, in seven European Countries, in an attempt to investigate whether and to which extent currently available screening methods may identify older people at risk of worsening kidney function.
Age
75 - No limit years
Sex
ALL
Healthy Volunteers
Yes
MEDIZINISCHE UNIVERSITAT- Internal Medicine/Nephrology/Geriatric Department
Graz, Austria
FRIEDRICH-ALEXANDER-UNIVERSITAT-Institute for Biomedicine of Aging
Erlangen, Germany
BEN-GURION UNIVERSITY-Geriatrics Department
Beersheba, Israel
INRCA Research Hospital
Ancona, Italy
INRCA Research Hospital
Cosenza, Italy
ERASMUS UNIVERSITAIR MEDISCH CENTRUM-Department of Internal Medicine
Rotterdam, Netherlands
UNIVERSYTET MEDYCZNY-Department of Geriatrics
Lodz, Poland
INSTITUT CATALA DE LA SALUT-Internal Medicine Deparment
Barcelona, Spain
SERVICIO MADRILENO DE SALUD-Geriatric Department
Madrid, Spain
Start Date
August 8, 2016
Primary Completion Date
March 10, 2020
Completion Date
March 10, 2020
Last Updated
June 24, 2020
2,434
ACTUAL participants
blood sample collection
OTHER
Lead Sponsor
Istituto Nazionale di Ricovero e Cura per Anziani
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07358572